ConductScience.org, home

Paper · 41111963

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139838397From diagnosis to treatment: exploring the mechanisms underlying optic neuritis in multiple sclerosis.J Transl Med2025https://conductscience.org/library/papers/39838397PubMed
230674597Optical coherence tomography for diagnosing optic neuritis: Are we there yet?Neurology2019https://conductscience.org/library/papers/30674597PubMed
340551221Optical coherence tomography angiography biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review.Int J Retina Vitreous2025https://conductscience.org/library/papers/40551221PubMed
435703428Longitudinal Retinal Changes in MOGAD.Ann Neurol2022https://conductscience.org/library/papers/35703428PubMed
538928637Macular OCT's Proficiency in Identifying Retrochiasmal Visual Pathway Lesions in Multiple Sclerosis-A Pilot Study.Diagnostics (Basel)2024https://conductscience.org/library/papers/38928637PubMed
636192175Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.Neurology2023https://conductscience.org/library/papers/36192175PubMed
735785363Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.Front Neurol2022https://conductscience.org/library/papers/35785363PubMed
838457885Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis.Mult Scler Relat Disord2024https://conductscience.org/library/papers/38457885PubMed
941523127Innovation in neuro-ophthalmology: The validation of smartphone-based self-screening for early detection of disorders.Taiwan J Ophthalmol2025https://conductscience.org/library/papers/41523127PubMed
1037221052
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
J Neurol Neurosurg Psychiatry2023https://conductscience.org/library/papers/37221052PubMed
1130239367Pediatric Optic Neuritis and Other Demyelinating Optic Neuropathies.Int Ophthalmol Clin2018https://conductscience.org/library/papers/30239367PubMed
1238965655AI in Neuro-Ophthalmology: Current Practice and Future Opportunities.J Neuroophthalmol2024https://conductscience.org/library/papers/38965655PubMed
1337795189Editorial: Application of multimodal imaging combined with artificial intelligence in eye diseases.Front Neurosci2023https://conductscience.org/library/papers/37795189PubMed
1436372866Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review.J Neurol2023https://conductscience.org/library/papers/36372866PubMed
1539213469Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis.Neurol Neuroimmunol Neuroinflamm2024https://conductscience.org/library/papers/39213469PubMed
1632124097Update on Pediatric Optic Neuritis.Curr Neurol Neurosci Rep2020https://conductscience.org/library/papers/32124097PubMed
1719439327Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.J Neurol Sci2009https://conductscience.org/library/papers/19439327PubMed
1839018513Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.Neurology2024https://conductscience.org/library/papers/39018513PubMed
1934566866MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.Front Neurol2021https://conductscience.org/library/papers/34566866PubMed
2039444702Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.Lancet Reg Health Eur2024https://conductscience.org/library/papers/39444702PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/41111963/references